| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Revenue | $94.4B | $91.4B | $88.9B | $82.7B | $67.4B | $14.7B | $19.1B |
| Cost of Revenue | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — |
| SG&A Expense | $16.5B | $15.8B | $15.3B | $16.4B | $13.5B | $12.4B | $11.5B |
| Operating Income | $17.6B | $15.6B | $12.9B | $12.1B | $7.8B | $0.6B | $3.4B |
| Net Income | $12.4B | $5.0B | $2.4B | $3.1B | $2.0B | $-0.7B | $1.1B |
| EPS (Basic) | $6.88 | $2.72 | $1.29 | $1.73 | $1.10 | $-0.39 | $0.58 |
| EPS (Diluted) | $6.85 | $2.72 | $1.29 | $1.72 | $1.09 | $-0.39 | $0.58 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Total Assets | $197.5B | $196.2B | $205.6B | $203.6B | $203.6B | $201.5B | $194.0B |
| Current Assets | $24.3B | $25.2B | $32.8B | $29.1B | $33.7B | $35.3B | $28.1B |
| Cash & Equivalents | $5.7B | $6.0B | $14.2B | $11.6B | $16.0B | $17.9B | $5.4B |
| Total Liabilities | — | — | — | — | — | — | — |
| Current Liabilities | $34.2B | $34.6B | $31.1B | $29.1B | $31.1B | $26.6B | $31.3B |
| Stockholders' Equity | $109.9B | $100.7B | $99.3B | $95.0B | $88.6B | $83.6B | $88.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $18.1B | — | — | — | — | — | — |
| Investing Cash Flow | $-8.0B | $-6.9B | — | — | — | — | — |
| Capital Expenditures | $8.0B | $5.4B | $5.0B | $4.9B | $3.6B | $4.0B | $4.9B |
| Financing Cash Flow | $-10.4B | — | — | — | — | — | — |